P-316: Dried blood spot C-peptide as a home monitoring tool for β-cell function in early-stage type 1 diabetes
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von A Clark und 5 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Screening programmes for Type 1 Diabetes (T1D) are expanding, helping to identify presymptomatic individuals. Monitoring changes in β-cell function is crucial for recognising stage 3 progression.
Objectives
To evaluate serial home-measured dried blood spot (DBS) fasting C-peptide as a tool for monitoring β-cell function and predicting T1D progression in the INNODIA paediatric cohort of first-degree relatives (FDR).
Methods
FDRs aged 1–18 years with ≥2 autoantibodies (IAb) were followed for up to 4 years with assessments including 6-monthly oral glucose tolerance tests (OGTTs) and monthly home DBS fasting C-peptide measurements. Linear mixed-effect models were fitted to evaluate DBS C-peptide over time.
Results
Seventy-one children (median [interquartile range] age 10.0 [6.5-12.8] years) collected 735 DBS (average of 6 cards per person [3.0-17.0]). Twenty (28.2%) progressed to stage 3 after a median of 18.6 (9.6-22.3) months. Baseline DBS C-peptide was lower in participants <10 years (n=35) compared to those 10-18 years-old (n=36): 213.5 (184.2-301.0) vs 398.0 (347.5-569.5) pmol/L, p<0.001, but C-peptide trajectories did not differ by age. Linear effects models adjusted for age, BMI, glucose, and sex demonstrated a significant positive association between ln(DBS fasting C-peptide) and ln(OGTT C-peptide area under the curve) (β= 0.25, p=0.025). DBS C-peptide increased more over time in those who seroconverted to IA-2A compared to those who did not (β =0.17, p=0.002). Stage 3 progressors had a significant decline in DBS C-peptide (β=-0.32, p=0.03) (Figure 1).
Conclusions
In this paediatric cohort of FDRs, DBS fasting C-peptide was lower in younger children than adolescents. Dynamic changes in DBS C-peptide were observed around IA-2A seroconversion, and a steep decline occurred before progression to stage 3. Home-based DBS C-peptide may offer a less invasive approach for monitoring IAb positive individuals.
Zitieren
APA
Clark, A., Waelkens, B., Bombaci, B., Mathieu, C., Hendriks, E., & Marcovecchio, M. L. (2026). P-316: Dried blood spot C-peptide as a home monitoring tool for β-cell function in early-stage type 1 diabetes. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.374
Vancouver
Clark A, Waelkens B, Bombaci B, Mathieu C, Hendriks E, Marcovecchio ML. P-316: Dried blood spot C-peptide as a home monitoring tool for β-cell function in early-stage type 1 diabetes. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.374
BibTeX
@article{Clark2026,
author = {Clark, A and Waelkens, B and Bombaci, B and Mathieu, C and Hendriks, E and Marcovecchio, M L},
title = {P-316: Dried blood spot C-peptide as a home monitoring tool for β-cell function in early-stage type 1 diabetes},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.374}
}
EUVIMED